BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2651483)

  • 1. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients.
    Hogewind WF; van der Kwast WA; van der Waal I
    J Craniomaxillofac Surg; 1989 Apr; 17(3):128-33. PubMed ID: 2651483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.
    Lumerman H; Freedman P; Kerpel S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):321-9. PubMed ID: 7621010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferative verrucous leukoplakia. Report of five cases].
    Reichart PA; Philipsen HP
    Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
    Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
    BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premalignant oral mucosal diseases.
    Melrose RJ
    J Calif Dent Assoc; 2001 Aug; 29(8):593-600. PubMed ID: 11577670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of proliferative verrucous leukoplakia to oral carcinoma: a ten years follow-up.
    Navarro CM; Sposto MR; Sgavioli-Massucato EM; Onofre MA
    Med Oral; 2004; 9(3):229-33. PubMed ID: 15122125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Gorecki P; Neukam FW; Strassburg LH; Nkenke E
    Cancer Invest; 2012 Aug; 30(7):495-502. PubMed ID: 22646284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proliferating cell nuclear antigen (PCNA) in oral leukoplakia].
    Qiao B; Yu S; Pang S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jul; 30(4):210-1. PubMed ID: 8745441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
    Warnakulasuriya S; Ariyawardana A
    J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral leukoplakia: A clinicopathological study and malignant transformation.
    Tovaru S; Costache M; Perlea P; Caramida M; Totan C; Warnakulasuriya S; Parlatescu I
    Oral Dis; 2023 May; 29(4):1454-1463. PubMed ID: 34982498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
    Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
    Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.